论文部分内容阅读
目的讨论子宫内膜癌患者血清脂联素水平与胰岛素抵抗指数的变化及相关性。方法以我院在2015年1月至2016年3月收治的40例子宫内膜癌患者作为观察组进行研究,对照组选择在门诊体检健康的妇女40例。观察两组的血清脂联素水平与胰岛素抵抗指数之间的关系。结果观察组的胰岛素指数、血糖水平以及脂联素水平、胰岛素抵抗指数明显高于对照组,两组之间存在显著差异,P<0.05,有统计学意义。脂联素和胰岛素抵抗指数呈负相关。结论在子宫内膜癌患者的脂联素水平降低以后,导致其胰岛素的抵抗指数增强,从而导致肿瘤细胞的增殖,严重威胁患者的身体健康。
Objective To investigate the changes and correlations of serum adiponectin level and insulin resistance index in patients with endometrial cancer. Methods Forty patients with endometrial cancer who were treated in our hospital from January 2015 to March 2016 were selected as the observation group and 40 healthy women in the control group were enrolled in the study. The relationship between serum adiponectin level and insulin resistance index was observed. Results Insulin index, blood glucose level and adiponectin level in the observation group were significantly higher than those in the control group. There was significant difference between the two groups (P <0.05), with statistical significance. Adiponectin and insulin resistance index was negatively correlated. Conclusions The reduction of adiponectin in patients with endometrial cancer leads to the increase of its insulin resistance index, leading to the proliferation of tumor cells and seriously threatening the health of patients.